Compare BLCO & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | HXL |
|---|---|---|
| Founded | 1853 | 1946 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.0B |
| IPO Year | 2022 | N/A |
| Metric | BLCO | HXL |
|---|---|---|
| Price | $17.44 | $79.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 8 |
| Target Price | $17.31 | ★ $72.88 |
| AVG Volume (30 Days) | 360.9K | ★ 1.2M |
| Earning Date | 02-18-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 0.87% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.84 |
| Revenue | ★ $4,976,000,000.00 | $1,876,400,000.00 |
| Revenue This Year | $8.06 | $0.16 |
| Revenue Next Year | $5.79 | $10.23 |
| P/E Ratio | ★ N/A | $93.01 |
| Revenue Growth | ★ 6.23 | N/A |
| 52 Week Low | $10.45 | $45.28 |
| 52 Week High | $18.34 | $79.20 |
| Indicator | BLCO | HXL |
|---|---|---|
| Relative Strength Index (RSI) | 62.34 | 64.93 |
| Support Level | $16.22 | $76.18 |
| Resistance Level | $17.26 | $78.89 |
| Average True Range (ATR) | 0.34 | 1.49 |
| MACD | -0.03 | 0.21 |
| Stochastic Oscillator | 91.73 | 94.88 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in the commercial aerospace, defense, and high-performance automotive markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.